Function announced the closing of $450 million in growth financing from General Catalyst’s Customer Value Fund. The financing will accelerate the company’s mission to help millions more people understand and take ownership of their health.
Since its early beta launch in 2023, Function has brought lab testing, imaging, and personalized intelligence into a single platform. The new capital will enable Function to bring its platform to more people faster.
The financing follows Function’s second-quarter expansion acquisitions of Getlabs’ nationwide at-home and office blood draw network and SuppCo’s supplement platform. Function offers access to more than 160 lab tests, including biannual testing, starting at $365 per year. The company also offers MRI and CT scanning for an additional cost below $1,000, available across more than 200 locations nationwide.
General Catalyst is a global investment and transformation company with offices in San Francisco, New York City, Boston, Berlin, Bangalore, and London. The firm has supported the growth of more than 800 businesses, including Airbnb, Anduril, Applied Intuition, Commure, Glean, Guild, Gusto, Helsing, HubSpot, Kayak, Livongo, Mistral, Ramp, Samsara, Snap, Stripe, Sword, and Zepto.
KEY QUOTES:
Our mission is simple: enable you to live 100 healthy years. Everyone deserves to feel their best and avoid suffering. Every dollar invested in Function is a vote for one hundred healthy years for eight billion people. This growth financing allows us to pull the inevitable and optimistic future of health into the present.
Jonathan Swerdlin, Co-Founder and CEO of Function
This financing reflects our belief that Function is one of the defining companies of our generation. Function has created an entirely new approach to health that we have never had before. We believe Function is uniquely positioned to reach millions more people, and we’re proud to support the next phase of its growth.
Pranav Singhvi, Partner and Co-Head of CVF, General Catalyst
